| Title: | The Association between Vitamin D and Incident Herpes Zoster: A UK Biobank Study |
| Journal: | British Journal of General Practice |
| Published: | 4 Apr 2022 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/35940884/ |
| DOI: | https://doi.org/10.3399/bjgp.2021.0623 |
| URL: | https://bjgp.org/content/bjgp/early/2022/08/08/BJGP.2021.0623.full.pdf |
Publication 13899
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
BACKGROUND: Vitamin D has immunomodulatory effects, but any association with herpes zoster (HZ) is unclear.</p>
AIM: To explore the association between vitamin D status and risk of incident HZ in adults in the UK.</p>
DESIGN AND SETTING: A cohort study involving participants of UK Biobank (a database containing the health information from half a million individuals) across England, Wales, and Scotland, who had at least one vitamin D testing result with linked primary care electronic health records.</p>
METHOD: The primary exposure was vitamin D status, categorised as deficient (<25 nmol/L), insufficient (25-49 nmol/L), or sufficient (≥50 nmol/L). The secondary exposures were self-reported vitamin D supplementation at baseline assessment and vitamin D prescription records. The outcome was diagnosed incident HZ, identified from linked primary care or hospital inpatient records. Weibull regression was used, adjusting for potential confounders, including demographic factors, comorbidities, and immunosuppression.</p>
RESULTS: In total, 177 572 eligible participants were included in the analysis, with a mean follow-up time of 10.1 years (standard deviation 1.9 years). No evidence showed that low vitamin D was associated with a higher incidence of HZ, compared with people with sufficient vitamin D (deficient: adjusted hazard ratio [HR] 0.99, 95% confidence interval [CI] = 0.90 to 1.10; insufficient: HR 1.03, 95% CI = 0.96 to 1.10). No evidence was found that supplementing vitamin D or receiving vitamin D prescription was associated with HZ incidence (supplementation: HR 0.88, 95% CI = 0.67 to 1.16; prescription: HR 1.11, 95% CI = 0.91 to 1.34).</p>
CONCLUSION: No association of vitamin D status, supplementation, or prescription with incident HZ was observed. No evidence supported vitamin D supplementation as a strategy to prevent HZ.</p>
9 Keywords
- Adult
- Biological Specimen Banks
- Cohort Studies
- Herpes Zoster
- Humans
- United Kingdom
- Vitamin D
- Vitamin D Deficiency
- Vitamins
6 Authors
- Liang-Yu Lin
- Rohini Mathur
- Amy Mulick
- Liam Smeeth
- Sinéad M Langan
- Charlotte Warren-Gash
1 Application
| Application ID | Title |
|---|---|
| 51265 | Association between serum vitamin D deficiency and the risk of herpes zoster: a longitudinal UK Biobank study |
Enabling scientific discoveries that improve human health